Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide

Cancer Letters

Volumn 110, Issue 1-2, 1996, Pages 77-85

  Huang, Tze Sing ^a,c   Shu, Chih Hung ^b   Shih, Yung Luen ^a   Huang, Huey Chung ^a   Su, Yi Chun ^a   Chao, Yee ^b   Yang, Wen K ^a   Whang Peng, Jacqueline ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Etoposide (VP 16); GL331; Protein tyrosine kinase; Protein tyrosine phosphatase

Indexed keywords

DNA FRAGMENT; ETOPOSIDE; GL 331; GYRASE INHIBITOR; OKADAIC ACID; PODOPHYLLOTOXIN DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG; VANADATE SODIUM; ZINC CHLORIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DNA DEGRADATION; DRUG STRUCTURE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NASOPHARYNX CANCER; PRIORITY JOURNAL; STOMACH CANCER; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; DNA FRAGMENTATION; DNA TOPOISOMERASES, TYPE II; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ETOPOSIDE; LETHAL DOSE 50; PODOPHYLLOTOXIN; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; TUMOR CELLS, CULTURED;

EID: 0030596182     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04464-3     Document Type: Article

References (30)

1. [1] Wang, Z.Q., Kuo, Y.H., Schnur, D., Bowen, P., Liu, S.Y., Han, F.S., Chang, J.Y., Cheng, Y.C. and Lee, K.H. (1990) Antitumor agents. 113 new 4b-arylamino derivatives of 4′-O-demethylepipodophyllotoxic and related compounds as potent inhibitors of human DNA topoisomerase II, J. Med. Chem., 33, 2660-2665.
2. [2] Liu, L.F. (1989) DNA topoisomerase poisons as antitumor drugs, Annu. Rev. Biochem., 58, 351-375.
3. [3] Lock, R.B. and Ross, W.E. (1987) DNA topoisomerases in cancer therapy, Anticancer Drug Design, 2, 151-164.
4. [4] Bodley, A.L. and Liu, L.F. (1988) Topoisomerases as novel targets for cancer chemotherapy, Biotechnology, 6, 1315-1319.
5. [5] Kautmann, S.H. (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note, Cancer Res., 49, 5870-5878.
6. cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells, Cancer Res., 50, 3767-3771.
7. [7] Martin, S.J., Green, D.R. and Cotter, T.G. (1994) Dicing with death: dissecting the components of the apoptosis machinery, Trends Biochem. Sci., 19, 26-30.
8. [8] Catchpoole, D.R. and Stewart, B.W. (1995) Formation of apoptotic bodies is associated with internucleosomal DNA fragmentation during drug-induced apoptosis, Exp. Cell Res., 216, 169-177.
9. [9] Sullivan, D.M., Chow, K.C. and Ross, W.E. (1989) Topoisomerase II mediated mechanisms of drug resistance. In: Resistance to Antineoplastic Drugs, pp. 281-292. Editor: D. Kessel. CRC Press, Boca Raton, FL.
10. 2 arrest in Chinese hamster ovary cells, Cancer Res., 50, 3761-3766.
11. cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide, Cancer Res., 52, 1817-1822.
12. cdc2 activation required for apoptosis, Science, 263, 1143-1145.
13. cdc2 coincident with taxol-induced apoptosis, Cell Growth Differ., 5, 1041-1050.
14. [14] Collins, M.K., Marvel, J., Malde, P. and Lopez-Rivas, A. (1992) Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents, J. Exp. Med., 176, 1043-1051.
15. [15] Miyashita, T. and Reed, J.C. (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line, Blood, 81, 151-157.
16. [16] Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-619.
17. [17] Mishra, S. and Hamburger, A.W. (1993) O-Phospho-L-tyrosine inhibits cellular growth by activating protein tyrosine phosphatases, Cancer Res., 53, 557-563.
18. [18] Hunter, T. and Cooper, J.A.(1985) Protein tyrosine kinases. Annu. Rev. Biochem., 54, 897-930.
19. [19] Cantley, L.C., Auger, K.R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R. and Soltoff, S. (1991) Oncogenes and signal transduction, Cell, 64, 281-302.
20. [20] Charbonneau, H. and Tonks, N.K.(1992) Protein phosphatase. Annu. Rev. Cell Biol., 8, 463-493.
21. [21] Fischer, E.H., Charbonneau, H. and Tonks, N.K. (1993) Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes, Science, 253, 401-406.
22. [22] Frank, D. A. and Sartorelli, A.C. (1986) Regulation of protein phosphotyrosine content by changes in tyrosine kinase and protein phosphotyrosine phosphatase activities during induced granulocytic and monocytic differentiation of HL-60 leukemia cells, Biochem. Biophys. Res. Commun., 140, 440-447.
23. [23] Frank, D.A. and Sartorelli, A.C. (1988) Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells, Cancer Res., 48, 52-58.
24. [24] Kuo, M.L., Huang, T.S. and Lin, J.K. (1995) Preferential requirement for protein tyrosine phosphatase activity in the 12-O-tetradecanoylphorbol-13-acetate-induced differentiation of human colon cancer cells, Biochem. Pharmaco., 50, 1217-1222.
25. [25] Azuma, Y., Onishi, Y., Sato, Y. and Kizaki, H. (1993) Induction of mouse thymocyte apoptosis by inhibitors of tyrosine kinases is associated with dephosphorylation of nuclear proteins, Cell Immunol., 152, 271-278.
26. [26] Bates, S.E., Currier, S.J., Alvarez, M. and Fojo, A.T. (1992) Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate, Biochemistry, 31, 6366-6372.
27. [27] Aftab, D.T., Yang, J.M. and Hait, W.N. (1994) Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells, Oncol. Res., 6, 59-70.
28. [28] Lee, W.P. (1995) P-glycoprotein is hyperphosphorylated in multidrug resistant HOB1 lymphoma cells treated with overdose of vincristine, Biochim. Biophys. Acta, 1245, 57-61.
29. [29] May, W.S., Tyler, P.G., Ito, T., Armstrong, D.K., Qatsha, K.A. and Davidson, N.E. (1994) Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of Bcl2α in association with suppression of apoptosis, J. Biol. Chem., 269, 26865-26870.
30. [30] Haldar, S., Jena, N. and Croce, C.M. (1995) Inactivation of Bcl-2 by phosphorylation, Proc. Natl. Acad. Sci. USA, 92, 4507-4511.